Sonendo, Inc. develops, manufactures, and sells devices for root canal therapy in the United States and Canada. It offers GentleWave, a device to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. Sonendo, Inc. was incorporated in 2006 and is based in Laguna Hills, California.
IPO Year: 2021
Exchange: NYSE
Website: sonendo.com
Date | Price Target | Rating | Analyst |
---|---|---|---|
3/12/2024 | Buy → Hold | Stifel | |
1/31/2022 | $6.90 | Equal-Weight | Morgan Stanley |
11/23/2021 | $16.00 | Buy | Stifel |
11/23/2021 | $15.00 | Buy | B of A Securities |
11/23/2021 | $30.00 | Buy | Goldman Sachs |
11/23/2021 | $17.00 | Overweight | Piper Sandler |